- A generic equivalent of Malarone (atovaquone/proguanil) has been launched for the prophylaxis and treatment of acute uncomplicated P. falciparum malaria.
- The antidiabetic combination tablet Komboglyze (metformin/saxagliptin) is now indicated for use in combination with a sulfonylurea when a sulfonylurea plus metformin is inadequate.
- A licensed oral suspension of clobazam, Tapclob, has been launched for use as an adjunct in epilepsy.
- Isentress (raltegravir) is now available as chewable tablets to treat HIV-1 infection in children from the age of 2 years.
- The cannabis-based MS spasticity treatment Sativex has been reclassified as a Schedule 4 CD, meaning that it can now be prescribed as a POM without any restrictions.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.